What anti-inflammatories (Non-Steroidal Anti-Inflammatory Drugs) are associated with arrhythmias?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Non-steroidal anti-inflammatory drugs (NSAIDs) and selective cyclo-oxygenase-2 (COX-2) inhibitors are associated with an increased risk of arrhythmias, particularly atrial fibrillation (AF).

Key Findings

  • The use of NSAIDs and COX-2 inhibitors increases the risk of AF, particularly in new users, with an incidence rate ratio of 1.33 (1.26–1.41) for non-selective NSAIDs and 1.50 (1.42–1.59) for selective COX-2 inhibitors 1.
  • The association is strongest for new users, with a risk increase of 1.46 (1.33–1.62) for non-selective NSAIDs and 1.71 (1.56–1.88) for COX-2 inhibitors 1.
  • Celecoxib is not associated with an increased risk of AF 1.

Mechanisms

  • NSAIDs may increase the risk of AF through renal and cardiovascular related actions that increase blood pressure and plasma volume, and reduce the antiarrhythmic and anti-inflammatory effects of prostacyclin via a COX-2 inhibition 1.
  • The increased risk tends to disappear following NSAID treatment discontinuation 1.

Important Considerations

  • The risk of AF is greater at the beginning of NSAID therapy, for short-term use, and in those treated with high doses 1.
  • Corticosteroids, particularly oral corticosteroids, may also increase the risk of AF, especially at high doses (≥ 7.5 mg of prednisone equivalents) 1.

From the Research

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Arrhythmias

  • The use of NSAIDs has been associated with an increased risk of atrial fibrillation (AF) 2, 3, 4.
  • A meta-analysis found that NSAID use was associated with a pooled risk ratio of AF of 1.29 (95% CI 1.19-1.39) compared to non-NSAID users 4.
  • Specific NSAIDs, such as ibuprofen, naproxen, and diclofenac, have been found to be associated with an increased risk of AF, with pooled risk ratios of 1.30,1.44, and 1.37, respectively 4.
  • Another study found that new NSAID use may predispose patients to AF, and the risk is almost doubled in heart failure patients 3.
  • The effects of NSAIDs on ventricular arrhythmias are not well established and would require further investigations 2.

Types of Arrhythmias Associated with NSAIDs

  • Atrial fibrillation (AF) is the most common type of arrhythmia associated with NSAID use 2, 3, 4.
  • Ventricular arrhythmias have been associated with oral steroids, but the evidence for NSAIDs is limited 5.
  • Supraventricular tachycardia has been associated with long-term use of oral steroids and short-term use of theophylline, but the evidence for NSAIDs is limited 5.

Patient Populations at Risk

  • Patients with heart failure are at a higher risk of developing AF when using NSAIDs 3.
  • Patients with chronic kidney or pulmonary disease may be at a higher risk of developing AF when using selective COX2 inhibitors 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pro- and anti-arrhythmic effects of anti-inflammatory drugs.

Anti-inflammatory & anti-allergy agents in medicinal chemistry, 2013

Research

Nonsteroidal anti-inflammatory drugs and incidence of atrial fibrillation: a meta-analysis.

QJM : monthly journal of the Association of Physicians, 2020

Research

Respiratory medications and the risk of cardiac arrhythmias.

Epidemiology (Cambridge, Mass.), 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.